Treatment of Gastro-Intestinal Disorders (Hungary)
Our partner is a medical research institute. The institute has developed, based on the Kynurenic Acid research, a molecule with highly protective effects in the gastrointestinal system. The substance is an analogue of the naturally occurring substance (kynurenic acid) with highly protective effects in the gastrointestinal system. The target of the molecule is mainly excitatory receptors. It may also have some influence on MS. In vivo and in vitro tests were performed on male wistar rats, mice and actually on dogs. Already performed and published studies: - Neuroprotective effect of L-kynurenine sulfate administered before focal cerebral ischemia in mice and global cerebral ischemia in gerbils - Kynurenic acid inhibits intestinal hypermotility and xanthine oxidase activity during experimental colon obstruction in dogs
Sector: Biotechnology
Country: Hungary
Area of Application: Pharmacological values, effects of the molecule could be interesting for the pharmacological industry.
Keywords: Pharmacologic, molecule, gastrointestinal
Advantages: - The molecule has highly protective effects in the gastrointestinal system - The substance is an analogue of the naturally occurring substance (kynurenic acid) - The target of the molecule is mainly excitatory receptors
Environmental aspects:
Development Status:
Legal Protection: Patent
Technical specifications:
Transfer Terms: Joint Venture , Technology Licensing
Target Countries:
Estimated cost (US$):
Upload any relevant document:
Contact Person: Laser Consult Ltd (Hungary)
Address: H-6701 PO Box 1191.
City: Szeged
Country: Hungary
Zip/Pin Code: